225 related articles for article (PubMed ID: 9841601)
1. Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5-year, population-based study.
Bloch KC; Zwerling L; Pletcher MJ; Hahn JA; Gerberding JL; Ostroff SM; Vugia DJ; Reingold AL
Ann Intern Med; 1998 Nov; 129(9):698-704. PubMed ID: 9841601
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterium kansasii and M. scrofulaceum isolates from HIV-negative South African gold miners: incidence, clinical significance and radiology.
Corbett EL; Hay M; Churchyard GJ; Herselman P; Clayton T; Williams BG; Hayes R; Mulder D; De Cock KM
Int J Tuberc Lung Dis; 1999 Jun; 3(6):501-7. PubMed ID: 10383063
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterium kansasii and human immunodeficiency virus co-infection in London.
Klein JL; Corbett EL; Slade PM; Miller RF; Coker RJ
J Infect; 1998 Nov; 37(3):252-9. PubMed ID: 9892529
[TBL] [Abstract][Full Text] [Related]
4. [Infections with Mycobacterium kansasii in the Academic Medical Center in Amsterdam: the changing clinical spectrum since the start of the HIV epidemic].
van der Meer JT; Kerssemakers SP; van Steenwijk RP; Kuijper EJ
Ned Tijdschr Geneeskd; 1998 Apr; 142(17):965-9. PubMed ID: 9623171
[TBL] [Abstract][Full Text] [Related]
5. Clinical and radiological features of Mycobacterium kansasii infection and Mycobacterium simiae infection.
Shitrit D; Peled N; Bishara J; Priess R; Pitlik S; Samra Z; Kramer MR
Respir Med; 2008 Nov; 102(11):1598-603. PubMed ID: 18619826
[TBL] [Abstract][Full Text] [Related]
6. The impact of HIV infection on Mycobacterium kansasii disease in South African gold miners.
Corbett EL; Churchyard GJ; Hay M; Herselman P; Clayton T; Williams B; Hayes R; Mulder D; De Cock KM
Am J Respir Crit Care Med; 1999 Jul; 160(1):10-4. PubMed ID: 10390373
[TBL] [Abstract][Full Text] [Related]
7. [Infection due to Mycobacterium kansasii in Elche, Spain].
Rodríguez JC; Ayelo A; Ruiz M; López M; Royo G
Med Clin (Barc); 2003 Mar; 120(7):253-4. PubMed ID: 12623000
[TBL] [Abstract][Full Text] [Related]
8. Incidence and molecular typing of Mycobacterium kansasii in a defined geographical area in Catalonia, Spain.
Santin M; Alcaide F; Benitez MA; Salazar A; Ardanuy C; Podzamczer D; Rufi G; Dorca J; Martin R; Gudiol F
Epidemiol Infect; 2004 Jun; 132(3):425-32. PubMed ID: 15188712
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and epidemiological study of disease caused by Mycobacterium kansasii in the metropolitan area of Bilbao, Spain].
Leal Arranz MV; Gaafar A; Unzaga Barañano MJ; Crespo Notario JA; Cisterna Cáncer R; García Cebrián F
Arch Bronconeumol; 2005 Apr; 41(4):189-96. PubMed ID: 15826528
[TBL] [Abstract][Full Text] [Related]
10. Mortality prediction in pulmonary Mycobacterium kansasii infection and human immunodeficiency virus.
Marras TK; Morris A; Gonzalez LC; Daley CL
Am J Respir Crit Care Med; 2004 Oct; 170(7):793-8. PubMed ID: 15215152
[TBL] [Abstract][Full Text] [Related]
11. Pathologic features of Mycobacterium kansasii infection in patients with acquired immunodeficiency syndrome.
Smith MB; Molina CP; Schnadig VJ; Boyars MC; Aronson JF
Arch Pathol Lab Med; 2003 May; 127(5):554-60. PubMed ID: 12708897
[TBL] [Abstract][Full Text] [Related]
12. Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California.
Nuorti JP; Butler JC; Gelling L; Kool JL; Reingold AL; Vugia DJ
Ann Intern Med; 2000 Feb; 132(3):182-90. PubMed ID: 10651598
[TBL] [Abstract][Full Text] [Related]
13. Clinical, radiological and molecular features of Mycobacterium kansasii pulmonary disease.
Bakuła Z; Kościuch J; Safianowska A; Proboszcz M; Bielecki J; van Ingen J; Krenke R; Jagielski T
Respir Med; 2018 Jun; 139():91-100. PubMed ID: 29858008
[TBL] [Abstract][Full Text] [Related]
14. Detailed analysis of the radiographic presentation of Mycobacterium kansasii lung disease in patients with HIV infection.
Cattamanchi A; Nahid P; Marras TK; Gotway MB; Lee TJ; Gonzalez LC; Morris A; Webb WR; Osmond DH; Daley CL
Chest; 2008 Apr; 133(4):875-80. PubMed ID: 18263685
[TBL] [Abstract][Full Text] [Related]
15. Mycobacterium kansasii in HIV patients: clarithromycin and antiretroviral effects.
Tompkins JC; Witzig RS
Int J Tuberc Lung Dis; 2007 Mar; 11(3):331-7. PubMed ID: 17352101
[TBL] [Abstract][Full Text] [Related]
16. [Clinical importance of Mycobacterium kansasii and evaluation of the need to identify nontuberculous mycobacteria].
Etxebarrieta M; Rodrigo A; Martín C; Ojer M; Ruz A; Dorronsoro I
Enferm Infecc Microbiol Clin; 2002 Mar; 20(3):113-6. PubMed ID: 11904083
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of Mycobacterium kansasii infection from Mycobacterium tuberculosis infection: comparison of clinical features, radiological appearance, and outcome.
Shitrit D; Priess R; Peled N; Bishara G; Shlomi D; Kramer MR
Eur J Clin Microbiol Infect Dis; 2007 Oct; 26(10):679-84. PubMed ID: 17629758
[TBL] [Abstract][Full Text] [Related]
18. Mycobacterium kansasii infection in patients infected with the human immunodeficiency virus.
Pintado V; Gómez-Mampaso E; Martín-Dávila P; Cobo J; Navas E; Quereda C; Fortún J; Guerrero A
Eur J Clin Microbiol Infect Dis; 1999 Aug; 18(8):582-6. PubMed ID: 10517196
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterium kansasii pulmonary diseases in Korea.
Yim JJ; Park YK; Lew WJ; Bai GH; Han SK; Shim YS
J Korean Med Sci; 2005 Dec; 20(6):957-60. PubMed ID: 16361804
[TBL] [Abstract][Full Text] [Related]
20. Clinical and radiographic manifestations of uncommon pulmonary nontuberculous mycobacterial disease in AIDS patients.
El-Solh AA; Nopper J; Abdul-Khoudoud MR; Sherif SM; Aquilina AT; Grant BJ
Chest; 1998 Jul; 114(1):138-45. PubMed ID: 9674460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
